Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer

Author:    

Publisher: Spandidos Publications

E-ISSN: 1791-2431|34|5|2683-2691

ISSN: 1021-335X

Source: Oncology Reports, Vol.34, Iss.5, 2015-01, pp. : 2683-2691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content